Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments

NCT01994031 is registered in ClinicalTrials.gov with Nanjing Luye Sike Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01994031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01994031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
Lead sponsor
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2014
Completion date
Not reported
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors